Hypertensive disorders of pregnancy are an
important cause of severe morbidity, long-term
disability and death among both pregnant women
and their babies, and account for approximately
14% of all maternal deaths worldwide. Improving
care for women around the time of childbirth is
a necessary step towards...
The Department of Reproductive Health and Research of the World Health Organization
gratefully acknowledges the contributions of many individuals and organizations to
the updating of these recommendations. Work on this update was coordinated by
Olufemi Oladapo, Joshua Vogel and A. Metin Gülmezoglu of th...
DESCRIPTION: The American College of Physicians (ACP) and the American Academy of Family Physicians (AAFP) jointly developed this guideline to present the evidence and provide clinical recommendations based on the benefits and harms of higher versus lower blood pressure targets for the treatment of hyper...
El presente documento reemplaza algunas recomendaciones presentadas en la GPC de HTA eincorpora nuevos elementos antes no considerados. Su alcance está enmarcado por laaplicabilidad en el contexto nacional para la prevención, diagnóstico, tratamiento integral yseguimiento de pacientes con HTA. Así mi...
Ballarín Castán, José Aurelio;
García López, Fernando;
Ibeas López, José;
Juárez Vela, Raúl;
Ortega Marlasca, Manuel María;
Pequeño Saco, Sandra;
Pérez Contreras, Francisco Javier;
Pérez Maraver, Manuel;
Rigau Comas, David;
Ruiz Hidalgo, Domingo;
anabria Uribe, Andrea Juliana;
Saracho Rotaeche, Ramón.
Objetivos: Esta GPC sobre Enfermedad Renal Crónica (ERC) responde a preguntas clínicas concernientes a su detección precoz, derivación a atención especializada y manejo, tanto mediante tratamiento farmacológico como con medidas higiénico dietéticas, estilos de vida e intervenciones educativas. As...
Renal Insufficiency, Chronic/diagnosis,
Renal Insufficiency, Chronic/therapy,
Ultrasonography/methods,
Angiotensin-Converting Enzyme Inhibitors/therapeutic use,
Antihypertensive Agents/therapeutic use,
Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use,
GRADE Approach,
Life Style,
Diet, Sodium-Restricted,
Diet, Protein-Restricted,
Angiotensin Receptor Antagonists/therapeutic use
OBJECTIVE: The objective is to formulate clinical practice guidelines for treating Cushing's syndrome. PARTICIPANTS: Participants include an Endocrine Society-appointed Task Force of experts, a methodologist, and a medical writer. The European Society for Endocrinology co-sponsored the guideline. EVIDENC...
Considerando que, los numerales I y II del Título Preliminar de la Ley N° 26842, Ley General de Salud disponen que la salud es condición indispensable del desarrollo humano y medio fundamental para alcanzar el bienestar individual y colectivo, y que la protección de la salud es de interés público. ...
This guideline covers the care and treatment of people with, or at risk of developing, chronic kidney disease. It aims to prevent or delay the progression of chronic kidney disease, reduce or prevent the development of complications, and reduce the risk of cardiovascular disease....
DESCRIPTION: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the screening, monitoring, and treatment of adults with stage 1 to 3 chronic kidney disease. METHODS: This guideline is based on a systematic evidence review eval...
Renal Insufficiency, Chronic/diagnosis,
Renal Insufficiency, Chronic/drug therapy,
Disease Progression,
Triage,
Angiotensin Receptor Antagonists/therapeutic use,
Angiotensin-Converting Enzyme Inhibitors/therapeutic use,
Antihypertensive Agents/therapeutic use,
Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use,
Hypolipidemic Agents/therapeutic use,
Gemfibrozil/therapeutic use,
Asymptomatic Diseases,
Drug Therapy, Combination,
GRADE Approach
